未登录

T

Ti Wen

China Medical University

H指数:27

被引数:1,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ANXA10 sensitizes microsatellite instability-high colorectal cancer to anti-PD-1 immunotherapy via assembly of HLA-DR dimers by regulating CD74

CELL BIOLOGY AND TOXICOLOGY

IF5.9

2025-01-100

OAAI

Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-12-240

OAAI

TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-06-011

PRE

Unveiling the role of KRAS in tumor immune microenvironment

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-02-0116

OAAI

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept (vol 43, 8, 2024)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-01-180

OAAI

Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview

用于增强癌症免疫治疗的多种药物递送系统: 概述

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-1717

OAAI

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

胰腺导管腺癌中基于肿瘤免疫微环境的治疗: 更新概念的时间

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-01-0216

OAAI

Editorial: Gastrointestinal cancer immune response and immune related adverse effects

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-180

OAAI

DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression (vol 9, 491, 2019)

FRONTIERS IN ONCOLOGY

IF3.3

2022-02-241

OAAI

Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3

IF10.1

2022-02-0119

OAAI

A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-2619

OAAI

Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/CDK2 axis promotes progression of ER plus breast cancer and confers tamoxifen resistance

IF3.9

2020-10-2433

OAAI

Systematic profiling of alternative splicing inHelicobacter pylori-negative gastric cancer and their clinical significance

CANCER CELL INTERNATIONAL

IF6

2020-06-309

OAAI

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28

外泌体PD-L1和CD28联合预测的Anti-PD-1治疗反应

FRONTIERS IN ONCOLOGY

IF3.3

2020-05-2750

OAAI

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients

FRONTIERS IN ONCOLOGY

IF3.3

2020-04-2253

OAAI

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-04-0323

OAAI

Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells

NATURE IMMUNOLOGY

IF27.6

2020-03-0918

OAAI

DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression

FRONTIERS IN ONCOLOGY

IF3.3

2019-06-1229

OAAI

Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2019-05-13155

PREAI

MicroRNA-1224 Inhibits Tumor Metastasis in Intestinal-Type Gastric Cancer by Directly Targeting FAK

FRONTIERS IN ONCOLOGY

IF3.3

2019-04-0433

OAAI